Latisse is the only FDA approved prescription treatment for inadequate lashes, and it is formulated to stimulate the growth of longer, fuller, and darker eyelashes. This treatment enhances eyelash growth through a once-nightly application topically to the base of the upper eyelashes.
Created by Allergan, a pharmaceutical leader in eye care products, Latisse originated from the active ingredient of a medicated eye drop that reduced elevated pressure inside of the eye. One of the side effects of these drops was longer, darker, fuller eyelashes. After this discovery, Allergan began studying bimatoprost, the main component of the medication, for the purpose of eyelash growth. Latisse was approved in 2008 by the FDA and has been prescribed for this purpose since.
Latisse is able to promote a fuller lash line because it contains bimatoprost, a medication that augments hair growth. The eyelash hair cycle is affected by Latisse in two ways:
You may not be a candidate for Latisse if you are:
The most common side effect of Latisse is an itchy sensation in the eyes and redness of the eyes. This side effect was reported in approximately 4% of patients enrolled in the clinical trial. Less common side effects include darkening of the iris or the coloured part of the eye (a change that may be permanent), darkening of the eyelid skin around the area of application (a change that may be reversible), redness of the eye lids, and dry and irritated eyes.
Be sure to consult with your optometrist to determine if Latisse is right for you.